Effect of aspirin on cardiovascular events and bleeding in the healthy elderly

QR Code

Effect of aspirin on cardiovascular events and bleeding in the healthy elderly

Background: Aspirin is a well-established therapy for the secondary prevention of cardiovascular events. However, its role in the primary prevention of cardiovascular disease is unclear, especially in older persons, who have an increased risk. Methods: From 2010 through 2014, we enrolled community-d...

Full description

Bibliographic Details
Main Authors:	McNeil, J., Wolfe, R., Woods, R., Tonkin, A., Donnan, G., Nelson, M., Reid, Christopher, Lockery, J., Kirpach, B., Storey, E., Shah, R., Williamson, J., Margolis, K., Ernst, M., Abhayaratna, W., Stocks, N., Fitzgerald, S., Orchard, S., Trevaks, R., Beilin, L., Johnston, C., Ryan, J., Radziszewska, B., Jelinek, M., Malik, M., Eaton, C., Brauer, D., Cloud, G., Wood, E., Mahady, S., Satterfield, S., Grimm, R., Murray, A.
Format:	Journal Article
Published:	Massachusetts Medical Society 2018
Online Access:	http://hdl.handle.net/20.500.11937/73952

Similar Items

Effect of aspirin on disability-free survival in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

Effect of aspirin on all-cause mortality in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2019)

Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2017)

ASPREE-D: Aspirin for the prevention of depression in the elderly
by: Berk, M., et al.
Published: (2016)

The aspirin in reducing events in the elderly trial: Statistical analysis plan
by: Wolfe, R., et al.
Published: (2018)

Quality of Life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors
by: Stocks, N., et al.
Published: (2018)

Impact of the 2017 AmericanHeart Association and American College of Cardiology hypertension guideline in aged individuals
by: Chowdhury, Enayet, et al.
Published: (2020)

Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
by: Robman, L., et al.
Published: (2017)

The Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA study
by: Ward, S., et al.
Published: (2018)

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
by: Ryan, Joanne, et al.
Published: (2020)

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
by: Grimm, R., et al.
Published: (2013)

Aspirin for the prevention of cognitive decline in the elderly: Rationale and design of a neuro-vascular imaging study (ENVIS-ion)
by: Reid, Christopher, et al.
Published: (2012)

Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial
by: Berk, M., et al.
Published: (2020)

Normative performance of healthy older individuals on the Modified Mini-Mental State (3MS) examination according to ethno-racial group, gender, age, and education level
by: Ryan, J., et al.
Published: (2018)

Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: A Cross-sectional Study
by: Chowdhury, Enayet, et al.
Published: (2020)

Genetic variation in PEAR1, cardiovascular outcomes and effects of aspirin in a healthy elderly population
by: Lewis, J.P., et al.
Published: (2020)

Slowing the progression of age-related hearing loss: Rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial
by: Lowthian, J., et al.
Published: (2016)

Effect of aspirin on cancer incidence and mortality in older adults.
by: McNeil, John J, et al.
Published: (2020)

Prevalence of chronic kidney disease in the elderly using the ASPirin in Reducing Events in the Elderly (ASPREE) study cohort
by: Polkinghorne, K., et al.
Published: (2019)

Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults
by: Mohebbi, M., et al.
Published: (2017)

Overcoming challenges to data quality in the ASPREE clinical trial
by: Lockery, J.E., et al.
Published: (2019)

Prediction of disability-free survival in healthy older people
by: Neumann, J.T., et al.
Published: (2022)

Simple Synthetic Receptors for Aspirin
by: Nguyen, Thanh Vinh, et al.
Published: (2014)

Dipyridamole plus aspirin versus aspirin alone in the secondary prevention after TIA or stroke: a meta-analysis by risk
by: Halkes, P.H.A., et al.
Published: (2008)

Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults
by: Zhou, Z., et al.
Published: (2020)

Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)

Patterns of Association between Depressive Symptoms and Chronic Medical Morbidities in Older Adults
by: Agustini, B., et al.
Published: (2020)

Twisted Aspirin Crystals
by: Cui, X., et al.
Published: (2013)

A randomised controlled trial of triple antiplatelet therapy (Aspirin, Clopidogrel and Dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility
by: Sprigg, Nikola, et al.
Published: (2008)

Selective binding and release of aspirin by an encapsulating receptor
by: Nguyen, Thanh Vinh, et al.
Published: (2010)

Is there a link between aspirin therapy and stroke severity
by: Bath, Philip M.W.
Published: (2007)

Associations of body size with all-cause and cause-specific mortality in healthy older adults
by: Carr, P.R., et al.
Published: (2023)

Optimising medication data collection in a large-scale clinical trial
by: Lockery, J.E., et al.
Published: (2019)

Predictive Performance of a Polygenic Risk Score for Incident Ischemic Stroke in a Healthy Older Population
by: Neumann, J.T., et al.
Published: (2021)

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
by: Bath, Philip M.W., et al.
Published: (2018)

Social isolation, social support and loneliness as predictors of cardiovascular disease incidence and mortality
by: Freak-Poli, R., et al.
Published: (2021)

Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial
by: Islam, R.M., et al.
Published: (2022)

A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial data
by: Neumann, J.T., et al.
Published: (2022)

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
by: Sacco, Ralph L., et al.
Published: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8rcrm2qcnasfbr0uck1ic3rkta